The allure of treating chronic metabolic conditions with an easy stick-on patch is understandably tempting for many whove struggled with painful injections, weight stigma, and difficulty controlling diabetes
New Options for TFL Beneficiaries (2026) TrumpRx.gov (launched Feb 5, 2026): Zepbound at ~$346/monthno insurance needed Foundayo (FDA approved April 1, 2026): Oral GLP-1 at ~$149/month self-pay CMS BALANCE Model : If enrolled in Medicare Part D (alongside TFL), check if your Part D plan participates in the BALANCE ModelMedicare Part D bridge begins July 2026 with $50/month copay TRICARE For Life members: see our Medicare guide for 2026 policy updates that may affect your Part D coverage
Not suitable for everyone, particularly those with heart conditions or high blood pressure
" I suspect the pill will be priced somewhere around about 80 to start with, progressing to 130 [for the intermediate dose], and maybe 160 for the top dose." However, he says that exact prices are yet to be announced, and that the greater competition among GLP-1 medications could lead to the prices of some treatment options reducing in the coming years